Similarly, the methylation level of the Ki67 ≤ 10% group was below that of the Ki67 > 10% group, and samples with low average methylation were concentrated in IDH-mutant gliomas (Fig. 1E). The gene discussed is MKI67; the disease is central nervous system cancer.